PMID: 6399229Jan 1, 1984Paper

Corneal grafts in the second eye

Cornea
A A Khodadoust, Y Karnema

Abstract

A series of 51 patients with bilateral penetrating corneal grafts was followed for 1-12 years to assess the effect of the second eye corneal graft on the incidence of allograft rejection. In 33 patients (66 eyes) who had avascular grafts, there was no significant increase in the incidence of allograft rejection reaction after corneal transplantation in the second eye. In 18 patients (36 eyes) who had vascularized corneas, there was a twofold increase in the incidence of allograft rejection in the second as well as in the first corneal graft. Based on this observation and other reports cited in the literature, we offer contraindications for grafting of the second eye.

Citations

Apr 27, 2004·Experimental Eye Research·Keith M Meek, Craig Boote
Feb 22, 2005·Journal of Cataract and Refractive Surgery·Peter M PinskyDimitri Chernyak
Sep 28, 2000·Micron : the International Research and Review Journal for Microscopy·K M Meek, N J Fullwood
Nov 9, 2000·Progress in Retinal and Eye Research·K M Meek, A J Quantock
Jan 7, 2009·International Ophthalmology Clinics·Helene Lam, M Reza Dana
May 9, 2008·Eye & Contact Lens·Zeynep OzbekChristopher J Rapuano
Aug 1, 1989·Ophthalmology·D C Musch, R F Meyer
Mar 1, 1995·Ophthalmology·S J TuftC R Davison
Apr 16, 2011·Journal français d'ophtalmologie·E GuilbertV Borderie
Oct 24, 2007·Transplantation Proceedings·D SellamiJ Feki
Jun 19, 2007·Survey of Ophthalmology·Anita PandaSatya Priya
Mar 1, 1990·Survey of Ophthalmology·S E Wilson, H E Kaufman
Jan 1, 2016·Vestnik oftalmologii·S V TrufanovD A Krakhmaleva

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.